Members
First name: Agnès Last name: Lefort Function: Researcher Position: Professor (internal medicine and infectious diseases specialist) Email: agnes.lefort aphp.fr |
Research interest
Antibiotic resistance
Education
Degree
2007: Research Director Degree (HDR)
2002: PhD
1996: MD (internal medicine and infectious diseases specialist)
2002: PhD
1996: MD (internal medicine and infectious diseases specialist)
Academic positions
2009-present: PUPH, Internal Medicine Ward, Beaujon Hospital and IAME, Paris-Diderot University
2005-2008: MCU-PH
2000-2004: Assistant
2005-2008: MCU-PH
2000-2004: Assistant
Research training (post doctoral)
2005 – present : Researcher at IAME
List of the main publications
Exhaustive list of publications
2024
Sokal A, Royer G, Esposito-Farese M, Clermont O, Condamine B, Laouénan C, Lefort A, Denamur E, de Lastours V, Colibafi, Septicoli and Coliville Groups
Clinical and bacteriological specificities of Escherichia coli bloodstream infections from biliary portal of entries.
The Journal of Infectious Diseases 2024, jiad586.
2023
Oliosi E, Rossi G, Nguyen Y, Honsel V, Bert F, Roux O, Fantin B, Lefort A
Enterococcal pyogenic liver abscesses: high risk of treatment failure and mortality.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2023, 42, 193-199.
Lefebvre T, Boutten A, Raulet-Bussian C, Raynor A, Manceau H, Puy H, Moulouel B, Schmitt C, Timsit JF, Lefort A, Weiss E, Lescure FX, Ricard JD, Sonneville R, Peoc'h K
Evaluation of iron metabolism in hospitalized COVID-19 patients.
Clinica Chimica Acta; International Journal of Clinical Chemistry 2023, 548, 117509.
Goulenok T, Seurat J, Selle AdL, Jullien V, Leflon-Guibout V, Grall N, Lescure FX, Lepeule R, Bertrand J, Fantin B, Burdet C, Lefort A
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
International Journal of Antimicrobial Agents 2023, 62, 106885.
Mallart E, Françoise U, Driessen M, Blanche S, Lortholary O, Lefort A, Caseris M, Fischer A, Mahlaoui N, Charlier C, PREPI study group
Pregnancy in primary immunodeficiency diseases: The PREPI study.
The Journal of Allergy and Clinical Immunology 2023, 152, 760-770.
Kimseng H, Rossi G, Danjean M, Jimenez-Araya B, Chaligne C, Galy A, Souhail B, Bert F, Leflon V, Fihman V, Caillault A, Demontant V, Seng S, Trawinski E, N 'Debi M, Boizeau L, Jacquier H, Ronot M, Reizine E, Le Roy V, Lefort A, Rodriguez C, Lepeule R, Woerther PL
Evaluation of the contribution of shotgun metagenomics in the microbiological diagnosis of liver abscesses.
The Journal of Infection 2023, 87, 365-372.
Dauny V, Dioguardi-Burgio M, Leflon-Guibout V, Bert F, Roux O, Houzé S, Lefort A, Rossi G
[Clinical and radiological differences between amoebic and pyogenic liver abscess: A case-control study].
La Revue De Medecine Interne 2023, 44, 472-478.
Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, Jaureguiberry S, Bernard L, Bruyere F, Gatey C, Abgrall S, Ferreyra M, Aumaitre H, Aparicio C, Garrait V, Meyssonnier V, Bourgarit-Durand A, Chabrol A, Piet E, Talarmin JP, Morrier M, Canoui E, Charlier C, Etienne M, Pacanowski J, Grall N, Desseaux K, Empana-Barat F, Madeleine I, Bercot B, Molina JM, Lefort A, PROSTASHORT Study Group
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2023, 76, 2154-2162.
Canouï E, Rossi G, Nguyen Y, Lafont E, Rossi B, Roux O, Dokmak S, Bert F, Leflon-Guibout V, Fantin B, Lefort A
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses.
Mycoses 2023, 66, 984-991.
Melenotte C, Aimanianda V, Slavin M, Aguado JM, Armstrong-James D, Chen YC, Husain S, Van Delden C, Saliba F, Lefort A, Botterel F, Lortholary O
Invasive aspergillosis in liver transplant recipients.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2023, e14049.
Burgaya J, Marin J, Royer G, Condamine B, Gachet B, Clermont O, Jaureguy F, Burdet C, Lefort A, de Lastours V, Denamur E, Galardini M, Blanquart F, Colibafi/Septicoli & Coliville groups
The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans.
PLoS genetics 2023, 19, e1010842.
Serris A, Coussement J, Pilmis B, De Lastours V, Dinh A, Parquin F, Epailly E, Ader F, Lortholary O, Morelon E, Kamar N, Forcade E, Lebeaux D, Dumortier J, Conti F, Lefort A, Scemla A, Kaminski H
New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting.
Transplant International: Official Journal of the European Society for Organ Transplantation 2023, 36, 11859.
2022
Rossi G, Nguyen Y, Lafont E, Rossi B, Canouï E, Roux O, Dokmak S, Bert F, Fantin B, Lefort A
Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses.
Infection 2022, 50, 1205-1215.
Lemaitre M, Galy A, de Lastours V, Thill P, Tattevin P, Lefort A
The intravenous vancomycin prescription practices of French infectious disease specialists: A cross-sectional observational study.
Infectious Diseases Now 2022, 52, 414-417.
Rollin G, Rossi B, Brisse S, Decré D, Leflon-Guibout V, Bert F, Hoffmann I, Decousser JW, Fantin B, Lefort A
Spontaneous and postsurgical/traumatic Klebsiella pneumoniae meningitis: two distinct clinico-microbiological entities.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 114, 185-191.
Royer G, Clermont O, Condamine B, Mercier-Darty M, Laouénan C, Lefort A, Denamur E, de Lastours V, COLIBAFI and SEPTICOLI Groups
O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2022, 74, 364-366.
Denamur E, Condamine B, Esposito-Farèse M, Royer G, Clermont O, Laouenan C, Lefort A, de Lastours V, Galardini M, COLIBAFI, SEPTICOLI groups
Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.
PLoS genetics 2022, 18, e1010112.
2021
Chaussade H, Cazals X, Desoubeaux G, Jouvion G, Bougnoux ME, Lefort A, Rivoisy C, Desnos-Ollivier M, Chretien F, Chouaki T, Gruson B, Bernard L, Lortholary O, Lanternier F, French Mycosis study group
Central nervous system candidiasis beyond neonates: Lessons from a nationwide study.
Medical Mycology 2021, 59, 266-277.
Royer G, Darty MM, Clermont O, Condamine B, Laouenan C, Decousser JW, Vallenet D, Lefort A, de Lastours V, Denamur E, COLIBAFI and SEPTICOLI groups
Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period.
Genome Medicine 2021, 13, 77.
Mohamadi M, Babington-Ashaye A, Lefort A, Flahault A
Risks of Infection with SARS-CoV-2 Due to Contaminated Surfaces: A Scoping Review..
International journal of environmental research and public health 2021, 18,
2020
Canovas J, Petitjean G, Chau F, Le Monnier A, Fantin B, Lefort A
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 1416.e5-1416.e9.
de Lastours V, Laouénan C, Royer G, Carbonnelle E, Lepeule R, Esposito-Farèse M, Clermont O, Duval X, Fantin B, Mentré F, Decousser JW, Denamur E, Lefort A
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2334-2343.
Lafont E, Roux O, de Lastours V, Dokmak S, Leflon V, Fantin B, Lefort A
Pyogenic liver abscess in liver transplant recipient: A warning signal for the risk of recurrence and retransplantation.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2020, 22, e13360.
Tabibzadeh N, Mullaert J, Zafrani L, Balagny P, Frija-Masson J, Marin S, Lefort A, Vidal-Petiot E, Flamant M
Knowledge self-monitoring, efficiency, and determinants of self-confidence statement in multiple choice questions in medical students.
BMC medical education 2020, 20, 445.
2019
Cantier M, Sabben C, Adle-Biassette H, Louedec L, Delbosc S, Desilles JP, Journé C, Diallo D, Ou P, Klein I, Chau F, Lefort A, Iung B, Duval X, Olivot JM, Ho-Tin-Noe B, Michel JB, Sonneville R, Mazighi M
Neurologic Complications of Infective Endocarditis: A Joint Model for a Septic Thromboembolism and Inflammatory Small Vessel Disease.
Critical Care Medicine 2019, 47, e685-e692.
Arangalage D, Abtan J, Gaschignard J, Ceccaldi PF, Remini SA, Etienne I, Ruszniewski P, Plaisance P, De Lastours V, Lefort A, Faye A
Implementation of a large-scale simulation-based cardiovascular clinical examination course for undergraduate medical students - a pilot study.
BMC medical education 2019, 19, 361.
2018
Goulenok T, Chopin D, De Lastours V, Zarrouk V, Lepeule R, Fantin B, Lefort A
[Influenzae and pneumococcal vaccination rate in an internal medicine ward].
La Revue De Medecine Interne 2018, 39, 386-392.
Rossi B, Gasperini ML, Leflon-Guibout V, Gioanni A, de Lastours V, Rossi G, Dokmak S, Ronot M, Roux O, Nicolas-Chanoine MH, Fantin B, Lefort A
Hypervirulent Klebsiella pneumoniae in Cryptogenic Liver Abscesses, Paris, France.
Emerging Infectious Diseases 2018, 24, 221-229.
2017
Parize P, Muth E, Richaud C, Gratigny M, Pilmis B, Lamamy A, Mainardi JL, Cheval J, de Visser L, Jagorel F, Ben Yahia L, Bamba G, Dubois M, Join-Lambert O, Leruez-Ville M, Nassif X, Lefort A, Lanternier F, Suarez F, Lortholary O, Lecuit M, Eloit M
Untargeted next-generation sequencing-based first-line diagnosis of infection in immunocompromised adults: a multicentre, blinded, prospective study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 574.e1-574.e6.
Rivoisy C, Vena A, Schaeffer L, Charlier C, Fontanet A, Delahaye F, Bouza E, Lortholary O, Munoz P, Lefort A, French Mycoses Study Group & Grupo de Apoyo al Manejo de las Endocarditis enEspaña (GAMES)
Prosthetic valve Candida spp. endocarditis: new insights into long term prognosis - the ESCAPE study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017
Richaud C, De Lastours V, Panhard X, Petrover D, Bruno F, Lefort A
Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France.
Medicine 2017, 96, e7525.
Nguyen Y, Rossi B, Argy N, Baker C, Nickel B, Marti H, Zarrouk V, Houzé S, Fantin B, Lefort A
Autochthonous Case of Eosinophilic Meningitis Caused by Angiostrongylus cantonensis, France, 2016.
Emerging Infectious Diseases 2017, 23, 1045-1046.
2016
Roux D, Meyer G, Cymbalista F, Bouaziz JD, Falgarone G, Tesniere A, Gervais J, Cariou A, Peffault de Latour R, Marat M, Moenaert E, Guebli T, Rodriguez O, Lefort A, Dreyfuss D, Hajage D, Ricard JD
[Computerized ranking test in three French universities: Staff experience and students' feedback].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2016, 37, 166-172.
Rossi G, Lafont E, Gasperini L, Dokmak S, Ronot M, Rossi B, Zarrouk V, Fantin B, Lefort A
[Liver abscess].
La Revue De Medecine Interne 2016, 37, 827-833.
Alexandre K, Chau F, Guérin F, Massias L, Lefort A, Cattoir V, Fantin B
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2016
2015
Parienti JJ, Lucet JC, Lefort A, Armand-Lefèvre L, Wolff M, Caron F, Cattoir V, Yazdanpanah Y
Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance.
American Journal of Infection Control 2015, 43, e53-e59.
Rossi B, Soubirou J, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort A
Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
Antimicrobial Agents and Chemotherapy 2015, 32, 1708.
2014
Lefort A, Chau F, Lepeule R, Dubée V, Kitzis MD, Dion S, Fantin B
Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase.
International Journal of Antimicrobial Agents 2014, 43, 366-369.
Tattevin P, Revest M, Lefort A, Michelet C, Lortholary O
Fungal endocarditis: current challenges.
International Journal of Antimicrobial Agents 2014, 44, 290-294.
Pilmis B, Lefort A, Lecuit M, Join-Lambert O, Nassif X, Lortholary O, Charlier C
Endocarditis due to Neisseria mucosa: case report and review of 21 cases: a rare and severe cause of endocarditis.
The Journal of Infection 2014, 68, 601-604.
Lepeule R, Leflon-Guibout V, Vanjak D, Zahar JR, Lafaurie M, Besson C, Lefort A, Groupe des Référents en Infectiologie d’Île-de-France (GRIF)
Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.
Medecine Et Maladies Infectieuses 2014, 44, 530-534.
Roubaud Baudron C, Panhard X, Clermont O, Mentré F, Fantin B, Denamur E, Lefort A, COLIBAFI Group
Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome.
Epidemiology and Infection 2014, 142, 2672-2683.
Burdet C, Clermont O, Bonacorsi S, Laouénan C, Bingen E, Aujard Y, Mentré F, Lefort A, Denamur E, COLIBAFI Group
Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity.
The Pediatric Infectious Disease Journal 2014, 33, 872–879.
Surgers L, Bleibtreu A, Burdet C, Clermont O, Laouénan C, Lefort A, Mentré F, Carbonne B, Bingen E, Meynard JL, Denamur E, COLIBAFI Group
Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1035–1041.
Bourgeois-Nicolaos N, Nguyen TT, Defrance G, Massias L, Alavoine L, Lefort A, Noel V, Senneville E, Doucet-Populaire F, Mentré F, Andremont A, Duval X
The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.
Antimicrobial Agents and Chemotherapy 2014, 58, 2681–2687.
2013
Clermont O, Glodt J, Burdet C, Pognard D, Lefort A, Branger C, Denamur E, COLIBAFI Group Members
Complexity of Escherichia coli bacteremia pathophysiology evidenced by comparison of isolates from blood and portal of entry within single patients.
International journal of medical microbiology: IJMM 2013, 303, 529–532.
Rivière S, Lortholary O, Michon J, Bougnoux ME, Mainardi JL, Sendid B, Bretagne S, Lefort A
Aspergillus endocarditis in the era of new antifungals: major role for antigen detection.
The Journal of Infection 2013, 67, 85-88.
Lefort A
[Why should antibiotic therapy be avoided in case of acute infectious diarrhea?].
Presse Médicale (Paris, France: 1983) 2013, 42, 82-83.
2012
de Montmollin E, Corcos O, Noussair L, Leflon-Guibout V, Belmatoug N, Joly F, Lefort A
Retroperitoneal abscesses due to Nocardia farcinica: report of two cases in patients with malnutrition.
Infection 2012, 40, 93-96.
Froissart A, Gazaignes S, Gellen-Dautremer J, Leflon-Guibout V, Iakovlev G, Zarrouk V, Lefort A, Fantin B
[Intermittent prolonged fever triggered by efforts].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2012, 33, 519-521.
Genin A, Desir J, Lambert N, Biervliet M, Van Der Aa N, Pierquin G, Killian A, Tosi M, Urbina M, Lefort A, Libert F, Pirson I, Abramowicz M
Kinetochore KMN network gene CASC5 mutated in primary microcephaly.
Human Molecular Genetics 2012, 21, 5306-5317.
Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O, French Mycosis Study Group
Diagnosis, management and outcome of Candida endocarditis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, E99-E109.
Lepeule R, Ruppé E, Le P, Massias L, Chau F, Nucci A, Lefort A, Fantin B
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Antimicrobial Agents and Chemotherapy 2012, 56, 1376-1381.
2011
Lucet JC, Nicolas-Chanoine MH, Lefort A, Roy C, Diamantis S, Papy E, Riveros-Palacios O, Le Grand J, Rioux C, Fantin B, Ravaud P
Do case vignettes accurately reflect antibiotic prescription?.
Infection Control and Hospital Epidemiology 2011, 32, 1003-1009.
Lucet JC, Nicolas-Chanoine MH, Roy C, Riveros-Palacios O, Diamantis S, Le Grand J, Papy E, Rioux C, Fantin B, Lefort A, Ravaud P
Antibiotic use: knowledge and perceptions in two university hospitals.
The Journal of Antimicrobial Chemotherapy 2011, 66, 936-940.
Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, Mentré F, Wolff M, Denamur E, Branger C, COLIBAFI Group
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2011, 17, 557-565.
Chau F, Lefort A, Benadda S, Dubée V, Fantin B
Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strains..
Antimicrobial agents and chemotherapy 2011, 55, 395-398.
Dubée V, Chau F, Arthur M, Garry L, Benadda S, Mesnage S, Lefort A, Fantin B
The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalis..
Antimicrobial agents and chemotherapy 2011, 55, 910-912.
Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentré F, Fantin B, Wolff M, Denamur E, COLIBAFI Group
Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.
Journal of Clinical Microbiology 2011, 49, 777-783.
2010
Larivière D, Lefort A
[Acute swollen red leg]..
La Revue du praticien 2010, 60, 107-112.
2009
Lebeaux D, Lanternier F, Lefort A, Lecuit M, Lortholary O
[Risk of fungal disease during systemic diseases]..
Presse medicale (Paris, France : 1983) 2009, 38, 260-273.
Bravetti AL, Mesnage S, Lefort A, Chau F, Eckert C, Garry L, Arthur M, Fantin B
Contribution of the autolysin AtlA to the bactericidal activity of amoxicillin against Enterococcus faecalis JH2-2..
Antimicrobial agents and chemotherapy 2009, 53, 1667-1669.
2008
Lortholary O, Lefort A, Tod M, Chomat AM, Darras-Joly C, Cordonnier C
Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia..
The Lancet. Infectious diseases 2008, 8, 612-620.
Ruimy R, Dos-Santos M, Raskine L, Bert F, Masson R, Elbaz S, Bonnal C, Lucet JC, Lefort A, Fantin B, Wolff M, Hornstein M, Andremont A
Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered gram-positive cocci on direct smears..
Journal of clinical microbiology 2008, 46, 2045-2051.
Rouzet F, Dominguez Hernandez M, Hervatin F, Sarda-Mantel L, Lefort A, Duval X, Louedec L, Fantin B, Le Guludec D, Michel JB
Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis.
Circulation 2008, 117, 781-789.
de Lastours V, Guillemain R, Mainardi JL, Aubert A, Chevalier P, Lefort A, Podglajen I
Early diagnosis of disseminated Mycobacterium genavense infection..
Emerging infectious diseases 2008, 14, 346-347.
2007
Lefort A, Arlet G, Join-Lambert OF, Lecuit M, Lortholary O
Novel extended-spectrum beta-lactamase in Shigella sonnei..
Emerging infectious diseases 2007, 13, 653-654.
2004
Lefort A, Arthur M, Depardieu F, Chau F, Pouzet C, Courvalin P, Fantin B
Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
The Journal of Infectious Diseases 2004, 189, 90-97.
Lefort A, Pavie J, Garry L, Chau F, Fantin B
Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplanin..
Antimicrobial agents and chemotherapy 2004, 48, 1061-1064.
2003
Nazal EM, Belmatoug N, de Roquancourt A, Lefort A, Fantin B
Hypoparathyroidism preceding Riedel's thyroiditis..
European journal of internal medicine 2003, 14, 202-204.
Lefort A, Lafaurie M, Massias L, Petegnief Y, Saleh-Mghir A, Muller-Serieys C, Le Guludec D, Fantin B
Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditis..
Antimicrobial agents and chemotherapy 2003, 47, 216-222.
Lefort A, Garry L, Depardieu F, Courvalin P, Fantin B
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium..
Antimicrobial agents and chemotherapy 2003, 47, 3515-3518.
Pavie J, Lefort A, Ploy MC, Massias L, Chau F, Garry L, Denis F, Fantin B
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis..
Antimicrobial agents and chemotherapy 2003, 47, 2018-2021.
2002
Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi JL
Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France..
Archives of internal medicine 2002, 162, 2450-2456.
Pavie J, Lefort A, Zarrouk V, Chau F, Garry L, Leclercq R, Fantin B
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics..
Antimicrobial agents and chemotherapy 2002, 46, 3061-3064.
1997
Lefort A, Lortholary O, Dupouy-Camet J, Rousset JJ, Guillevin L
Imported trichinellosis from former Yugoslavia..
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 1997, 3, 506-507.